These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35156873)

  • 21. [Significance of NUDT15 gene in individualized treatment with 6-mercaptopurine in children with acute lymphoblastic leukemia].
    He J; Liu L
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jan; 21(1):100-104. PubMed ID: 30675872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of NUDT15 variants by targeted sequencing can identify compound heterozygosity in pediatric acute lymphoblastic leukemia patients.
    Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Raghav L; Chang HH; Wu KH; Chou SW; Ni YL; Lin DT; Lin SW; Chen HY; Yang YL
    Sci Rep; 2020 Sep; 10(1):14400. PubMed ID: 32873882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia.
    Tanaka Y; Kato M; Hasegawa D; Urayama KY; Nakadate H; Kondoh K; Nakamura K; Koh K; Komiyama T; Manabe A
    Br J Haematol; 2015 Oct; 171(1):109-15. PubMed ID: 26033531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging role of NUDT15 polymorphisms in 6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic leukaemia.
    Singh M; Bhatia P; Khera S; Trehan A
    Leuk Res; 2017 Nov; 62():17-22. PubMed ID: 28963908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mercaptopurine induced myelosuppression in a child with a
    Gupta N; Magatha LS; Jayaraman D; Scott JX; Antony SB; Koshy T
    J Oncol Pharm Pract; 2023 Jun; 29(4):999-1001. PubMed ID: 36341754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of
    Mao X; Yin R; Sun G; Zhou Y; Yang C; Fang C; Wu Y; Cui T; Liu L; Gan J; Tian X
    Front Pediatr; 2021; 9():719803. PubMed ID: 34660484
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia.
    Tanaka Y; Nakadate H; Kondoh K; Nakamura K; Koh K; Manabe A
    Pharmacogenomics J; 2018 Apr; 18(2):275-280. PubMed ID: 28418010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic Leukemia.
    Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Cheng CN; Chang HH; Chou SW; Su MY; Ni YL; Xu PY; Lin DT; Lin SW; Chen HY; Yang YL
    Sci Rep; 2023 Jan; 13(1):490. PubMed ID: 36627439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of NUDT15 on incidence of neutropenia in children with acute lymphoblastic leukemia.
    Buaboonnam J; Sripatanatadasakul P; Treesucon A; Glomglao W; Siraprapapat P; Narkbunnam N; Vathana N; Takpradit C; Phuakpet K; Pongtanakul B; Tongsai S; Sinlapamongkolkul P; Sanpakit K
    Pediatr Int; 2019 Aug; 61(8):754-758. PubMed ID: 31166660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel variants in
    Moriyama T; Yang YL; Nishii R; Ariffin H; Liu C; Lin TN; Yang W; Lin DT; Yu CH; Kham S; Pui CH; Evans WE; Jeha S; Relling MV; Yeoh AE; Yang JJ
    Blood; 2017 Sep; 130(10):1209-1212. PubMed ID: 28659275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to thiopurine toxicity by
    Correa-Jimenez O; Yunis JJ; Linares-Ballesteros A; Sarmiento-Urbina I
    Colomb Med (Cali); 2021; 52(3):e2074569. PubMed ID: 35431360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia.
    Liang DC; Yang CP; Liu HC; Jaing TH; Chen SH; Hung IJ; Yeh TC; Lin TH; Lai CL; Lai CY; Shih LY
    Pharmacogenomics J; 2016 Nov; 16(6):536-539. PubMed ID: 26503813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of TPMT and NUDT15 Genetic Polymorphisms on Mercaptopurine Pharmacokinetics in Healthy Volunteers.
    Kong Q; Zhang Q; Chen D; Lou J; Zhu J; Chen M; Li T
    Genet Test Mol Biomarkers; 2024 Aug; 28(8):322-327. PubMed ID: 39084859
    [No Abstract]   [Full Text] [Related]  

  • 34. TPMT and NUDT15 genes are both related to mercaptopurine intolerance in acute lymphoblastic leukaemia patients from Uruguay.
    Soler AM; Olano N; Méndez Y; Lopes A; Silveira A; Dabezies A; Castillo L; da Luz JA
    Br J Haematol; 2018 Apr; 181(2):252-255. PubMed ID: 28146264
    [No Abstract]   [Full Text] [Related]  

  • 35.
    Pai AA; Mohan A; Benjamin ESB; Illangeswaran RSS; Xavier Raj I; Janet NB; Arunachalam AK; Kavitha ML; Kulkarni U; Devasia AJ; Fouzia NA; Abraham A; Srivastava A; George B; Mathews V; Korula A; Balasubramanian P
    Pharmgenomics Pers Med; 2021; 14():1303-1313. PubMed ID: 34629890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry.
    Schaeffeler E; Jaeger SU; Klumpp V; Yang JJ; Igel S; Hinze L; Stanulla M; Schwab M
    Genet Med; 2019 Sep; 21(9):2145-2150. PubMed ID: 30728528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of
    Lee JM; Shim YJ; Kim DH; Jung N; Ha JS
    Children (Basel); 2021 Mar; 8(3):. PubMed ID: 33804051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT.
    Kim H; You S; Park Y; Choi JY; Ma Y; Hong KT; Koh KN; Yun S; Lee KH; Shin HY; Lee S; Yoo KH; Im HJ; Kang HJ; Kim JH
    Sci Rep; 2021 May; 11(1):9676. PubMed ID: 33958640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosage of 6-Mercaptopurine in Relation to Genetic TPMT and ITPA Variants: Toward Individualized Pediatric Acute Lymphoblastic Leukemia Maintenance Treatment.
    Kouwenberg TW; van den Bosch BJC; Bierau J; Te Loo DMWM; Coenen MJH; Hagleitner MM
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e94-e97. PubMed ID: 31895215
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Moradveisi B; Muwakkit S; Zamani F; Ghaderi E; Mohammadi E; Zgheib NK
    Front Pharmacol; 2019; 10():916. PubMed ID: 31507415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.